Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia
Clinical trial NCT04878731 · COMPLETED
Trial details
- NCT number
- NCT04878731
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-16
- Primary completion
- 2021-08-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.